Established in 2004, the French National Authority for Health (Haute Autorité de Santé, HAS) oversees key healthcare functions.
This study focuses on three core responsibilities: healthcare facility certification, chronic illness definition, and clinical practice guideline production.
Other HAS functions, like drug evaluation, were outside the scope of this analysis.
Purpose:
To critically evaluate the effectiveness of the French National Authority for Health (HAS) in three primary areas.
To identify shortcomings in healthcare facility certification, chronic illness (affections de longue durée, ALD) definition, and clinical practice guideline creation.
To propose alternative models for these HAS responsibilities.
Summary:
Healthcare facility certification by HAS is costly and lacks depth, with quality variations across departments.
The definition of chronic illnesses (ALD) is vague, leading to regional disparities in patient access.
Clinical practice guidelines require stronger scientific grounding and clearer, more concise presentation.
Overall HAS performance in these areas is deemed disappointing.
Impact:
Findings suggest that healthcare facility certification could be improved through unannounced inspections by other bodies.
Reassigning chronic illness definition and guideline production to scientific societies may enhance accuracy and consistency.
Recommendations aim to improve the quality and efficiency of French healthcare governance and patient care standards.